Dopamine Receptor d1 antibody (3rd Cytoplasmic Domain)
Quick Overview for Dopamine Receptor d1 antibody (3rd Cytoplasmic Domain) (ABIN1733780)
Target
See all Dopamine Receptor d1 (DRD1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- 3rd Cytoplasmic Domain
-
Specificity
- Reacts with human DRD1
-
Cross-Reactivity (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins.
-
Purification
- Antigen affinity purified
-
Immunogen
- Synthetic 15 amino acid peptide from 3rd cytoplasmic domain of human DRD1. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Gibbon (100%), Monkey (100%), Marmoset (100%), Elephant (100%), Panda (100%), Dog (100%) ...
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Working dilution: IHC - P (8 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-80 °C
-
Storage Comment
- Long term: -70°C, Short term: +4°C
-
-
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Alternative Name
- DRD1 / Dopamine Receptor D1
-
UniProt
- P21728
-
Pathways
- cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Target
-